Inhibition of eotaxin expression in human corneal fibroblasts by interferon-γ

International Archives of Allergy and Immunology

Volumn 129, Issue 2, 2002, Pages 138-144

  Fukuda, Ken ^a   Yamada, Naoyuki ^a   Fujitsu, Youichiro ^a   Kumagai, Naoki ^a   Nishida, Teruo ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corneal fibroblast; Eotaxin; Interferon

Indexed keywords

CYTOKINE; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL;

ADOLESCENT; ADULT; AGED; CHEMOKINES, CC; CHILD; CHILD, PRESCHOOL; CORNEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-4; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036976626     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065880     Document Type: Article

References (32)

1. Tuft SJ, Kemeny DM, Dart JK, Buckley RJ: Clinical features of atopic keratoconjunctivitis. Ophthalmology 1991;98:150-158.
2. Bacon AS, Tuft SJ, Metz DM, McGill JI, Buckley RJ, Baddeley S, Lightman SL: The origin of keratopathy in chronic allergic eye disease: A histopathological study. Eye 1993;7:21-25.
3. Cameron JA: Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. Ophthalmology 1995;102:985-993.
4. Cameron JA, Mullaney PB: Amblyopia resulting from shield ulcers and plaques of the cornea in vernal keratoconjunctivitis. J Pediatr Ophthalmol Strabismus 1997;34:261-262.
5. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D: Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979;123:2925-2927.
6. Trocmé SD, Kephart GM, Bourne WM, Buckley RJ, Gleich GJ: Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol 1993;115:640-643.
7. Trocmé SD, Gleich GJ, Kephart GM, Zieske JD: Eosinophil granule major basic protein inhibition of corneal epithelial wound healing. Invest Ophthalmol Vis Sci 1994;35:3051-3056.
8. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD: Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 1996;2:449-456.
9. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ: Eotaxin: A potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airway inflammation. J Exp Med 1994;179:881-887.
10. Rothenberg ME: Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am J Respir Cell Mol Biol 1999;21:291-295.
11. Fukagawa K, Nakajima T, Tsubota K, Shimmura S, Saito H, Hirai K: Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage. J Allergy Clin Immunol 1999;103:1220-1221.
12. Kumagai N, Fukuda K, Ishimura Y, Nishida T: Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-13. Invest Ophthalmol Vis Sci 2000;41:1448-1453.
13. Fukagawa K, Nakajima T, Saito H, Tsubota K, Shimmura S, Natori M, Hirai K: IL-4 induces eotaxin production in corneal keratocytes but not in epithelial cells. Int Arch Allergy Immunol 2000;121:144-150.
14. Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Simonelli C, Emmi L, De Carli M, Tiri A, Ricci M, Romagnani S: Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991;146:1169-1174.
15. Leonardi A, DeFranchis G, Zancanaro F, Crivellari G, De Paoli M, Plebani M, Secchi AG: Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry. Invest Ophthalmol Vis Sci 1999;40:3036-3040.
16. Lack G, Bradley KL, Hamelmann E, Renz H, Loader J, Leung DY, Larsen G, Gelfand EW: Nebulized IFN-γ inhibits the development of secondary allergic responses in mice. J Immunol 1996;157:1432-1439.
17. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Rugiu FS, De Carli M, Ricci M, Romagnani S: Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992;148:2142-2147.
18. Noble A, Staynov DZ, Kemeny DM: Generation of rat Th2-like cells in vitro is interleukin-4-dependent and inhibited by interferon-γ. Immunology 1993;79:562-567.
19. + T cells. J Exp Med 1993;177:573-576.
20. Nakajima H, Iwamoto I, Yoshida S: Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993;148:1102-1104.
21. Kung TT, Stelts D, Zurcher JA, Watnick AS, Jones H, Mauser PJ, Fernandez X, Umland S, Kreutner W, Chapman RW, Egan RW: Mechanisms of allergic pulmonary eosinophilia in the mouse. J Allergy Clin Immunol 1994;94:1217-1224.
22. Kumagai N, Fukuda K, Nishida T: Synergistic effect of TNF-α and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts. Biochem Biophys Res Commun 2000;279:1-5.
23. Resnick MB, Weller PF: Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993;8:349-355.
24. Lilly CM, Woodruff PG, Camargo CA Jr, Nakamura H, Drazen JM, Nadel ES, Hanrahan JP: Elevated plasma eotaxin levels in patients with acute asthma. J Allergy Clin Immunol 1999;104:786-790.
25. Yawalkar N, Uguccioni M, Schärer J, Braunwalder J, Karlen S, Dewald B, Braathen LR, Baggiolini M: Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999;113:43-48.
26. Zeibecoglou K, Macfarlane AJ, Ying S, Meng Q, Pavord I, Barnes NC, Robinson DS, Kay AB: Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge. Allergy 1999;54:730-735.
27. Phipps RP, Penney DP, Keng P, Silvera M, Harkins S, Derdak S: Immune functions of subpopulations of lung fibroblasts. Immunol Res 1990;9:275-286.
28. Sappino AP, Schürch W, Gabbiani G: Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63:144-161.
29. Xing Z, Jordana M, Braciak T, Ohtoshi T, Gauldie J: Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: Evidence for heterogeneity within the respiratory tract. Am J Respir Cell Mol Biol 1993;9:255-263.
30. Schmitt-Gräff A, Desmoulière A, Gabbiani G: Heterogeneity of myofibroblast phenotypic features: An example of fibroblastic cell plasticity. Virchows Arch 1994;425:3-24.
31. h1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro. Int Immunol 1999;11:1001-1004.
32. Hein H, Schlüter C, Kulke R, Christophers E, Schröder JM, Bartels J: Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem Biophys Res Commun 1997;237:537-542.